戻る
AstraZeneca and Daiichi Sankyo’s Datroway Demonstrates Survival Benefit in Breast Cancer Trial
戻る
株式ニュース
テーマ
AstraZeneca and Daiichi Sankyo’s Datroway Demonstrates Survival Benefit in Breast Cancer Trial
AstraZeneca and Daiichi Sankyo’s Datroway Demonstrates Survival Benefit in Breast Cancer Trial
Edgen Stock
·
Oct 06 2025, 20:13
共有先
共有先
リンクをコピー
ソース：
[1] AstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy
[2] AstraZeneca's DATROWAY shows survival benefit in metastatic TNBC By Investing.com
[3] AstraZeneca/Daiichi Sankyo Partnered Breast Cancer Drug Shows Survival Benefit Over Chemotherapy - Benzinga
Edgen Stock·Oct 06 2025, 20:13Edgen Stock·Oct 06 2025, 20:13
Edgen Stock·Oct 06 2025, 20:13